CLINICAL_TRIALS
trial_result
· 2025-10-15
Clinical Trial Update: Hidradenitis Suppurativa Study of Izokibep [Phase 3]
Summary
A Phase 3 trial of izokibep for hidradenitis suppurativa was terminated, with results posted in October 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ACELYRIN Inc. | Conditions: Hidradenitis Suppurativa | Phase 3 | Status: TERMINATED | Results posted: 2025-10-15